clinical trial · NCT06827262
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Chronic Low-back PainVertebrogenic Pain SyndromeIntracept™ Intraosseous Nerve Ablation
brief summary
Compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
started
Mar 26, 2025
primary completion
Jul 1, 2034
completion
Jul 1, 2034
last updated
May 7, 2026
detailed description
The objective of this study is to compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol